The Seattle Cancer Summit Fred Hutch, Pelton Auditorium
We live in a time of
tremendous possibility for cancer R&D. Checkpoint inhibitors, cell
therapies, molecular diagnostics that catch cancer early and can guide
effective custom treatment – these fields are brimming with progress. All were considered
speculative at best a decade ago. The science has never been more promising.
Yet pricing and access to this new world of cancer therapy remains thorny.
These issues have to be resolved if society is going to reap the benefits of
this work. Come hear from some of the leading scientists, entrepreneurs, and
investors about how they are thinking about the future. All ticket proceeds go
to the Kilimanjaro Climb to Fight Cancer, a philanthropic campaign to support
basic research at Fred Hutch.
NOTE: Last year’s
event sold out in advance, and space is limited. Buy your tickets early to save
your seat.
Confirmed speakers:
Gary Gilliland, president and director, Fred Hutch
Chad Robins, co-founder and CEO, Adaptive Biotechnologies
Steve Harr, co-founder and CEO, Sana Biotechnology
Charlotte Hubbert, partner, Gates Foundation Venture Capital
Peter Thompson, private equity partner, OrbiMed; co-founder,
Silverback Therapeutics
Sam Blackman, founder and chief medical officer, Day One
Therapeutics
Heidi Hagen, co-founder and chief strategy officer, Vineti*
Bob More, partner, Alta Partners*
Thong Le, CEO, Accelerator Life Science Partners
Clayton Knox, chief operating officer, Mavupharma
Kristin Anderson, postdoctoral fellow, Fred Hutch Phil
Greenberg Lab, Society for Immunotherapy of Cancer Presidential Award-winning
young investigator*
Racquel Bracken, vice president, Venrock
Brad Gray, CEO, NanoString Technologies
Tom Daniel, venture partner, ARCH Venture Partners
Kelly O’Brien, vice president of philanthropy, Fred Hutch*
Mark Litton, president and COO, Alpine Immune Sciences
Luke Timmerman, founder and editor, Timmerman Report*
Carla Grandori, co-founder and CEO,
SEngine Precision Medicine
Sponsors:
Veracyte
Alexandria Real Estate Equities
Takeda Pharmaceuticals
Foundation Medicine
Madryn Asset Management
Alexion
*Denotes Kilimanjaro
climber
Date:
Time: 1:30 PM - 5:30 PM
Address: 1100 Fairview Ave. N. Seattle, WA 98109